Astrazeneca Pharma India Ltd vs Zenith Drugs Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 12, 2026

Key Highlights

The Latest Trading Price of Astrazeneca Pharma India Ltd is ₹ 8243 as of 12 Jun 15:30 . The P/E Ratio of Astrazeneca Pharma India Ltd is 0 as of March 2022 .The P/E Ratio of Zenith Drugs Ltd is 0 as of March 2022 . The Market Cap of Astrazeneca Pharma India Ltd is ₹ 0 crore as of March 2022 .The Market Cap of Zenith Drugs Ltd is ₹ 0 crore as of March 2022 . The revenue of Astrazeneca Pharma India Ltd for the Mar '26 is ₹ 584.56 crore as compare to the Dec '25 revenue of ₹ 618.18 crore. This represent the decline of -5.44% The revenue of Zenith Drugs Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Astrazeneca Pharma India Ltd for the Mar '26 is ₹ 65.78 crore as compare to the Dec '25 ebitda of ₹ 51.44 crore. This represent the growth of 27.88% The ebitda of Zenith Drugs Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Astrazeneca Pharma India Ltd changed from ₹ -11.79 crore to ₹ 44.88 crore over 8 quarters. This represents a CAGR of NaN% The net profit of Zenith Drugs Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The Dividend Payout of Astrazeneca Pharma India Ltd changed from 5.36 % on March 2021 to 69.12 % on March 2025 . This represents a CAGR of 66.76% over 5 yearsThe Dividend Payout of Zenith Drugs Ltd changed from 8.99 % on March 2024 to 0 % on March 2025 . This represents a CAGR of -100.00% over 2 years .

About Astrazeneca Pharma India Ltd

AstraZeneca Pharma India Limited (APIL) was incorporated on July 11, 1979.
The Company is engaged in the business of manufacture, distribution and marketing of pharmaceutical products and co-ordinates clinical trial services with an overseas group company.
The major therapy areas where the company operates are Onocology, Alimentary & Metabolism, Cardio Vascular, Renal, Diabetes, Respiratory and Oncology. AstraZeneca Pharma India, formerly known as Astra-IDL (AIL), was an erstwhile joint venture of Astra Zeneca, UK and Hinduja controlled IDL. Astra Pharmaceuticals AB, Sweden acquired all of the 1287500 equity shares in the Company of IDL, representing 25.75% of the Company's issued and paid up equity share capital.
Consequently, the Company became a subsidiary of Astra, which is a direct wholly owned subsidiary of Astra AB, Sweden (now known as AstraZeneca Pharmaceuticals AB Sweden) and an indirect wholly owned subsidiary of AstraZeneca Plc, the Group parent Company.

About Zenith Drugs Ltd

Zenith Drugs Limited was originally incorporated on November 15, 2000 as a Private Limited Company as 'Zenith Drugs Private Limited' issued by the Registrar of Companies, in the State of Madhya Pradesh, Gwalior.
Subsequently, Company was converted into Public Limited and consequently, the name of the Company was changed to Zenith Drugs Limited' pursuance to issuance of a Fresh Certificate of Incorporation on September 13, 2023 by the Registrar of Companies, Gwalior. Zenith are a reputable pharmaceutical manufacturing and trading unit based out from Indore.
Zenith's core business centers on production of high-quality, cost-effective pharmaceutical formulations such as: ORS Powder; Liquid Orals; Oinments; Liquid Externals and Capsules.
With a diverse portfolio of formulations, the Company is specialized in manufacturing affordable and high quality medicines to meet the needs of patients.

FAQs for the comparison of Astrazeneca Pharma India Ltd and Zenith Drugs Ltd

Which company has a larger market capitalization, Astrazeneca Pharma India Ltd or Zenith Drugs Ltd?

Market cap of Astrazeneca Pharma India Ltd is 20,609 Cr while Market cap of Zenith Drugs Ltd is 77 Cr

What are the key factors driving the stock performance of Astrazeneca Pharma India Ltd and Zenith Drugs Ltd?

The stock performance of Astrazeneca Pharma India Ltd and Zenith Drugs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Astrazeneca Pharma India Ltd and Zenith Drugs Ltd?

As of June 12, 2026, the Astrazeneca Pharma India Ltd stock price is INR ₹8243.9. On the other hand, Zenith Drugs Ltd stock price is INR ₹45.35.

How do dividend payouts of Astrazeneca Pharma India Ltd and Zenith Drugs Ltd compare?

To compare the dividend payouts of Astrazeneca Pharma India Ltd and Zenith Drugs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.